https://www.raps.org/resource/industry-wants-more-transparency-dedicated-progra.html
Industry wants more transparency, dedicated program for complex generics in GDUFA IV | RAPS
The next iteration of the Generic Drug User Fee Amendments program should focus on enhancing communications between the US Food and Drug Administration (FDA)...
wants moregdufa ivindustrytransparencydedicated